Original Founders of Akkermansia Muciniphila Bring First Gut Health Product to U.S. Consumer Market
27 juin 2024 11h11 HE
|
The Akkermansia Company
The Akkermansia Company, founded by the first scientists to discover and decode Akkermansia muciniphila, announces its launch into the U.S. consumer market
Noom Introduces AI-Enabled Products to Enhance On-Demand Health Care and Interactive Coaching
27 juin 2024 08h04 HE
|
Noom Inc
Noom launches two state-of-the-art AI-powered features, AI food logging and Welli, Noom’s new AI personal health assistant.
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
24 juin 2024 07h00 HE
|
Rani Therapeutics, LLC
~ New RT-114 obesity program combines ProGen’s FC Fusion protein conjugated GLP-1/GLP-2 dual agonist, PG-102, with the RaniPill® capsule designed to provide a differentiated oral delivery mechanism...
High Use of Ozempic and Other Diabetes Drugs for Weight Loss Driving Down Clothing Sizes In New York City, According to New Study
17 juin 2024 07h00 HE
|
Impact Analytics
Impact Analytics announced that size small has become the most popular size for women on Manhattan’s Upper East Side.
Noom Announces Strategic Expansion of Executive Team with Key Leadership Appointments
13 juin 2024 12h14 HE
|
Noom Inc
Noom, the leading digital healthcare company, announces the appointment of three distinguished executives to its leadership team.
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT
27 mai 2024 10h31 HE
|
The Rosen Law Firm PA
NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and...
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
23 mai 2024 09h05 HE
|
ResMed Inc.
New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
Amplify ETFs Launches The Amplify Weight Loss Drug & Treatment ETF (THNR)
21 mai 2024 07h00 HE
|
Amplify ETFs
Amplify ETFs announces the launch of the Amplify Weight Loss Drug & Treatment ETF (NYSE: THNR).
ALT INVESTOR NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT
09 mai 2024 14h52 HE
|
The Rosen Law Firm PA
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of...
Noom Adds Muscle Defense™ to Its GLP-1 Companion Program to Help Prevent Muscle-Mass Loss While Taking GLP-1s
09 mai 2024 08h04 HE
|
Noom Inc
Noom launches Noom Move, an on-demand fitness offering, including Muscle Defense™, a curated movement program for those taking GLP-1 medications.